Osteoarthritis of one hip caused by hip dysplasia, where the specific side (right or left) has not been documented in the medical record.
Verified May 8, 2026 · 4 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 9
- Region
- Hip
Documentation tips
What should appear in the chart to support M16.30.
Source · Editorial brief grounded in 4 cited references ↓
- Record laterality by name (right or left) at every encounter — a single documented side converts M16.30 to the more specific M16.31 or M16.32 and closes the audit gap.
- Explicitly link the OA to a history of hip dysplasia or developmental dysplasia of the hip (DDH); without that etiologic connection, payers may reclassify as primary OA (M16.1x).
- Include imaging findings that support both the dysplastic anatomy and the degenerative changes — acetabular index, center-edge angle, joint space narrowing measurement, or Kellgren-Lawrence grade on plain film or CT.
- Document prior conservative management (physical therapy, NSAIDs, intra-articular injections) when the encounter is leading toward surgical authorization, as payers require this history for total hip arthroplasty pre-auth.
- If a prior DDH repair (Salter osteotomy, periacetabular osteotomy) is part of the history, note it — it corroborates the dysplastic etiology and may be relevant for secondary code assignment.
Related CPT procedures
Procedure codes commonly billed with M16.30. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M16.30 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M16.30 when the operative or imaging report clearly names the affected side — once laterality is documented anywhere in the encounter, use M16.31 (right) or M16.32 (left) instead.
- Using M16.30 for bilateral dysplastic OA — bilateral disease maps to M16.2, not to M16.30 or a combination of laterality codes.
- Defaulting to M16.30 (or any M16.3x) when the chart documents OA of the hip but does not explicitly attribute it to dysplasia — absent an etiologic link, primary OA codes (M16.10–M16.12) or M16.9 are more defensible.
- Confusing dysplastic OA (M16.3x) with post-traumatic OA (M16.5x) — the distinction turns on the documented cause; fracture or dislocation history points to M16.5x, congenital or developmental abnormality points to M16.3x.
- Omitting a secondary code for pain or functional limitation when the payer's clinical policy requires symptom documentation to authorize arthroplasty or advanced imaging.
Clinical context
Source · Editorial summary grounded in 4 cited references ↓
M16.30 captures dysplastic osteoarthritis affecting a single hip when the treating provider has not specified laterality. The underlying mechanism is structural: abnormal acetabular coverage or femoral head geometry from developmental dysplasia of the hip (DDH) creates abnormal contact stress, accelerating cartilage breakdown and producing secondary OA earlier than primary degenerative disease typically presents. The ICD-10-CM Tabular includes 'Dysplastic osteoarthritis of hip NOS' as an inclusion term under parent code M16.3.
Use M16.30 only when the chart genuinely omits laterality — for example, a referral note that documents dysplastic OA without specifying right or left. The moment the operative report, imaging read, or attending note names the side, move to M16.31 (right) or M16.32 (left). Leaving the code at M16.30 when laterality is available is an audit risk and may trigger a payer query or downcoding.
Do not confuse this code with adjacent M16 subcategories. M16.2 covers bilateral dysplastic OA. M16.5x covers post-traumatic unilateral OA. M16.7 covers other unilateral secondary OA. If the dysplastic etiology is not documented — only OA of the hip — default to M16.10 (unilateral primary, unspecified hip) or M16.9 (OA of hip, unspecified) rather than assuming a dysplastic origin.
Sibling codes
Other billable codes under M16.3 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 4 cited references ↓
01When should I use M16.30 instead of M16.31 or M16.32?
02How is M16.30 different from M16.10 (unilateral primary OA, unspecified hip)?
03Can M16.30 be used when both hips show dysplastic OA?
04Is a history of surgical DDH correction sufficient to justify M16.3x over M16.1x?
05What CPT codes are commonly filed with M16.30?
06Does M16.30 require a 7th character extension?
07Can I code M16.30 alongside a pain code?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M15-M19/M16-/M16.30
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M16.30
- 04allzonems.comhttps://www.allzonems.com/blogs/icd-10-musculoskeletal-coding-guide/
Mira AI Scribe
Mira AI Scribe captures the affected side, the patient's history of hip dysplasia or DDH (including any prior corrective surgery), and imaging findings — acetabular coverage angles, joint space narrowing, and osteophyte formation — that establish both the structural abnormality and the resulting OA. That capture prevents the encounter from landing on the unspecified M16.30 when a laterality-specific code is justified, eliminating the payer query that follows a missing side designation.
See how Mira captures M16.30 documentation